4) Cardiovascular Disease and Renal Function
نویسندگان
چکیده
منابع مشابه
Cystatin C, renal function, and cardiovascular risk.
Because all the patients had chronic kidney disease (CKD) (GFR <55 mL/min per 1.73 m 2 ), this study cannot be used to assert that cystatin C is definitively better than creatinine for detecting stage 3 kidney disease (GFR <60 mL/min per 1.73 m 2 ). Regarding the study methods, the authors do not mention when cystatin C was measured in the frozen samples. Were the samples measured retrospective...
متن کاملRenal disease, homocysteine, and cardiovascular complications.
Cardiovascular morbidity and mortality remain major problems in the end stage renal disease population.1 Patients with mild or moderate degrees of renal insufficiency are also at increased risk of a similar fate.2 The causes of this poor cardiovascular prognosis in patients with renal disease are complex although many abnormalities occur in patients with renal dysfunction which predispose to su...
متن کاملRelaxin in cardiovascular and renal disease.
Fibrosis (organ scarring) is a hallmark of many forms of cardiovascular and renal disease, and causes organ dysfunction and structural changes when normal tissue is replaced with scar tissue; the accumulation of scar tissue being a leading cause of death around the world. Despite deep organ scarring potentially existing in many forms (including myocardial and vascular sclerosis, renal interstit...
متن کاملSoluble Adiponectin is a New Predictor for Cardiovascular Complications in Patients with End Stage Renal Disease
Mortality due to cardiovascular complications (CVC) in patients with end stage renal disease (ESRD) is 20 fold higher than in general population. Adiponectin (ADPN) hormone from adipose tissues accumulation in serum is attributed to reduced renal clearance. The aim of this study was to investigate the possible role of ADPN as a predictor of CVC in adult patients with ESRD on hemodialysis (HD), ...
متن کاملCardiovascular and Renal Effects of Bromocriptine in Diabetic Patients with Stage 4 Chronic Kidney Disease
OBJECTIVE The objective of this study was to investigate the effect of bromocriptine (BEC) on left ventricular mass index (LVMI) and residual renal function (RRF) in chronic kidney disease (CKD) patients with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS A 6-month double-blind randomized controlled trial was conducted in 28 patients with T2D and stage 4 CKD with increased LVMI. Fourteen ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nihon Naika Gakkai Zasshi
سال: 2008
ISSN: 0021-5384,1883-2083
DOI: 10.2169/naika.97.91c